Management issues in hypertensive diabetics

Bibliography

• Deedwania PC. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy and selection of drug therapy. Cardiol Clin. 2005; 23: 137–152.
   Web of Science ®Google Scholar
• Sowers JR, Haffner S. Treatment of CV and renal risk factors in the diabetic hypertensive. Hypertension. 2002; 40: 781–788.
   PubMed Web of Science ®Google Scholar
• Tarnow L, Rossing P, Gall MA. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care. 1994; 17: 1247–1251.
   PubMed Web of Science ®Google Scholar
• Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Aric study. N Engl J Med. 2000; 342: 905–912.
   PubMed Web of Science ®Google Scholar
• Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med. 2004; 116 (Suppl 5A): 30S–38S.
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, et al; Advance Collaborative Group. Effects of a fixed combination of perindopril and indapamide on microvascular and microvascular outcomes in patients with type 2 diabetes mellitus (Advance trial): a randomized controlled trial. Lancet. 2007; 370: 829–840.
   PubMed Web of Science ®Google Scholar
• Ruilope LM. New advance in guidelines. J Hypertens. 2008; 26(Suppl 2): S16–S18.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575–1585.
   PubMed Web of Science ®Google Scholar
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998; 317: 703–713.
   PubMed Web of Science ®Google Scholar
• Nilsson PM, Cifkova R, Kjeldsen SE. Update on hypertension management: treatment of hypertension in patients with type 2 diabetes mellitus. J Hypertens. 2006; 24: 208–210.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension. 2007; 25: 1105–1187.
   PubMed Web of Science ®Google Scholar
• Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005; 165: 1410–1419.
   PubMed Web of Science ®Google Scholar
• Weber MA, Bakris GL, Jamerson K, et al; ACCOMPLISH Investigators. Cardiovascular events during differing hypertension therapies in patients with Diabetes. J Am Coll Cardiol. 2010; 56: 77–85.
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Blohmé G, Lapidus L, et al. Do antihypertensive drugs precipitate diabetes? BMJ. 1984; 289: 1495–1497.
   PubMed Web of Science ®Google Scholar
• Opie LH. Old antihypertensives and new diabetes. J Hypertens. 2004; 22: 1453–1458.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi G, Angeli F, et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension. 2004; 43: 963–969.
   PubMed Web of Science ®Google Scholar
• Shamiss A, Carroll J, Peleg E, et al. Enalapril with and without hydrochlorothiazide: effects on insulin sensitivity and metabolic abnormalities of NIDDM hypertensive patients. Am J Hypertens. 1995; 8: 276–281.
   PubMed Web of Science ®Google Scholar
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352: 854–865.
   PubMed Web of Science ®Google Scholar
• British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005; 91(Suppl V).1–52.
   PubMed Web of Science ®Google Scholar
• Costa J, Borges M, David C, Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. Lancet. 2006; 332: 1115.
   Google Scholar
• Bakris GL, Sowers JR. ASH Position Paper: Treatment of hypertension in patients with diabetes—an update. J Clin Hypertens. 2008; 10: 707–713.
   PubMed Web of Science ®Google Scholar